SCHEMBL5131744

SCHEMBL5131744

CC[C@@H](CO)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 9/20 0.57
CYP3A4 P08684 2/20 0.57
CES2 O00748 1/20 0.57
ABCB11 O95342 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
GLA P06280 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CHRM1 P11229 1/20 0.57
CYP2C9 P11712 1/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 1/20 0.57
TBXA2R P21731 1/20 0.57
AADAC P22760 1/20 0.57
MAPK1 P28482 1/20 0.57
CYP2C19 P33261 1/20 0.57
ADRA1A P35348 1/20 0.57
HTT P42858 1/20 0.57
HTR6 P50406 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131746 1.00 AR (0.57) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL5120820 0.83 AR (0.50) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL5120811 0.83 AR (0.50) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL25264862 0.82 AR (0.56) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL5126331 0.82 ALDH1A1 (0.50) CYP3A4ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL5126321 0.82 ALDH1A1 (0.50) CYP3A4ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL8318543 0.79 EGFR (0.48) ALDH1A1LMNAALOX15TSHRMAPK1
SCHEMBL11313476 0.78 AR (0.75) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL11510610 0.78 AR (0.75) ARCYP3A4CES2ABCB11ALDH1A1
SCHEMBL11511325 0.77 AR (0.77) ARCYP3A4CES2ABCB11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058383-A1 Androgen Receptor Modulators KARO BIO AB (SE) 2008-03-06 US claimed
US-20080058383-A1 Androgen Receptor Modulators KARO BIO AB (SE) 2008-03-06 US disclosed
US-20080058383-A1 Androgen Receptor Modulators KARO BIO AB (SE) 2008-03-06 US disclosed
US-20080058383-A1 Androgen Receptor Modulators KARO BIO AB (SE) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058383-A1 Androgen Receptor Modulators NR5A1, ESRRA, AR AR 3/4885CYP3A4 1601/4885CES2 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.